$ Value
$0
Shares
50,758
Price
$0
Filed
Jul 10
Insider
Name
Mendel Scott
Title
—
CIK
0001515051
Roles
Transaction Details
Transaction Date
2025-07-08
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
50,758
Footnotes
Received in exchange for 28,500 shares of Akoya Biosciences, Inc. ("Akoya") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Mr. Mendel received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share. | Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of the shares on each of July 8, 2026, July 8, 2027 and July 8, 2028. | Includes 24,464 restricted stock units. | The option vests as to one-third of the shares on July 8, 2026, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments.
Filing Info
Mendel Scott's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | QTRX | A | $0 |
| 2025-10-01 | QTRX | A | $12K |
| 2025-07-08 | AKYA | J | — |
| 2025-07-08 | AKYA | J | $0 |
| 2025-07-08 | AKYA | J | $0 |
| 2025-07-08 | AKYA | J | $0 |
| 2025-07-08 | AKYA | J | $0 |
| 2025-07-08 | AKYA | J | $0 |
| 2025-07-08 | QTRX | A | — |
| 2025-07-08 | QTRX | A | $0 |
Other Insiders at QTRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
DONNELLY WILLIAM P
Executive Chair
|
— | — | 2026-04-01 |
| Mendel Scott | — | — | 2026-04-01 |
|
Sriram Vandana
Chief Financial Officer
|
— | — | 2026-04-15 |
|
Miller Michael Francis
Chief Operating Officer
|
— | — | 2026-04-15 |